ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Conventional disease-modifying anti-rheumatic drugs combined with Chinese Herbal Medicines for rheumatoid arthritis: A systematic review and meta-analysis

Han, Rong; Ren, Hong Cheng; Zhou, Sitong; Gu, Sherman; Gu, Yue-Yu; Sze, Daniel Man-yuen*; Chen, Meng-Hua*广州中医药大学
JOURNAL OF TRADITIONAL AND COMPLEMENTARY MEDICINE2022-9DOI: 10.1016/j.jtcme.2022.01.005
8被引11阅读
引用收藏
分享

摘要

Rheumatoid Arthritis (RA) remains a major global public health challenge. Disease-modifying anti -rheumatic drugs (DMARDs) are standard therapeutic drugs for RA. Conventional DMARDs (c-DMARDs) are a subgroup of approved synthetic DMARDs. The c-DMARDs experienced lesser response with longer disease duration or drug exposure, and unwanted adverse events (AEs). The combination treatments (CTs) of c-DMARDs and Chinese Herbal Medicines (CHMs) were often used in RA clinical trials for increasing the therapeutic effectiveness and reducing the AEs. This systematic review aimed to evaluate the efficacy and safety of the CTs for RA. Databases were searched from inception to October 2020 for identification of randomized controlled trials (RCTs) that investigated the CTs in the management of RA. Twenty-three RCTs with 2,441 participants were included. The assessments and analyses found CTs improved American College of Rheumatology (ACR) 20 (RR: 1.33, 95% CI [1.21, 1.45], 10 studies, n=1,075) and alleviated AEs (RR:-0.40, 95% CI [-0.30,-0.53], 19 studies, n=2,011) in comparison with c-DMARDs. The CTs also significantly improved RA symptoms and patient-reported outcomes; reduced disease ac-tivity score (DAS) 28, serum acute-phase reactants and RA biomarkers. The five most commonly used herbs in included studies were Angelicae Sinensis Radix, Paeoniae Radix Alba, Cinnamomi Ramulus, Gly-cyrrhizae Radix et Rhizoma, and Clematidis Radix et Rhizoma. Pharmacological studies indicated these CHMs could contribute to the outcomes. The integrated CHMs potentially increased the overall effec-tiveness of c-DMARDs and alleviated AEs in management of RA. Large sample and rigorously designed RCTs are required for future studies.(c) 2022 Center for Food and Biomolecules, National Taiwan University. Production and hosting by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/).

学科与关键词

关键词
Chinese herbal medicineRheumatoid arthritisConventional disease -modifying antirheumatic drugsAdverse eventEf ficacy
相关
加载中…
  • Efficacy and safety of Duhuo-Jisheng decoction in rheumatoid arthritis: A systematic review and meta-analysis of 42 randomized controlled trials
    Qu, Pengda; Wang, Haiyang; Wang, Wei; Du, Shiyu; Peng, Zhaorong; Hu, Qian; Tang, Xiaohu*Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries, 2023, 102(44): e35513.
  • The combination of Chinese and Western Medicine in the management of rheumatoid arthritis: A real-world cohort study across China
    Zhong, Linda LD.*; Wang, Rongsheng; Lam, Wai Ching; Zhu, Qi; Du, Peipei; Cao, Pei Hua; Jiang, Ting; Zhang, Yuan Yuan; Shen, Jie; Su, Xiao; Xue, Luan; Mao, Jianchun; Fang, Yong Fei; Gao, Ming Li; Hu, Chun Rong; Peng, Jiang Yun; Gu, Ying; Wei, Qianghua; Huang, Runyue; Lyu, Aiping; Liu, Hongxia*; He, Dongyi*Frontiers in Pharmacology, 2022, 13: 933519.被引 2
  • Editorial: Disease-modifying antirheumatic drugs: Approaches and lessons learned from traditional medicine
    Mei, Liyan; Gao, Kaixin; He, Xiaojuan; Jakobsson, Per-Johan*; Huang, Runyue*Frontiers in Pharmacology, 2023, 14: 1135803.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
JOURNAL OF TRADITIONAL AND COMPLEMENTARY MEDICINE
发表日期
2022-09
卷期
第 12 卷, 第 5 期
页码
437-446
DOI
10.1016/j.jtcme.2022.01.005
成果收录
SCIE

作者

  • H

    Han, Rong (第一作者)

    hong kong polytech univ

  • R

    Ren, Hong Cheng

    hong kong polytech univ

查看全部 7 位作者收起作者
  • Z

    Zhou, Sitong

    hong kong polytech univ

  • G

    Gu, Sherman

  • G

    Gu, Yue-Yu

    guangdong prov acad chinese med sci · 2 · guangzhou univ chinese med

  • S

    Sze, Daniel Man-yuen (通讯)

  • C

    Chen, Meng-Hua (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417